about
The temporal impact of aging on the burden of herpes zoster.Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong.Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in NThe Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in KoreaComment on: 'Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada', Wilson et al., 22 June 2018Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United StatesContraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UKHow to assess for the full economic value of vaccines? From past to present, drawing lessons for the futureCost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years oldPublic Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
P50
Q36257901-E0867FED-2254-4BBD-B421-3FE162E3A09DQ37375921-CD870AFA-89FB-43AA-8C4A-657F05A73C42Q38678770-1C4F4321-FFFE-4EBE-9B18-8F3F50070A41Q52597282-10707C9F-5A53-49DF-9A9E-87BD14A54476Q54230925-9D12FE19-97C7-4BB8-B753-71B1A1098B7EQ57210543-A52D2EC9-B543-4D69-944A-38F3ECE91082Q58580875-3E7F10A2-487E-44C9-B785-BAAD4C4E55A6Q59356687-1D6C1118-EC5C-4EEF-8468-27E0058A4A76Q89455254-CA2AC39D-6814-4475-B61A-2741DCAB67AFQ90013854-F71D3005-898C-445A-B45A-7ED1B03168B1Q91063381-19E82F98-846A-4FA6-8782-3EFCE9DF2A7AQ93093594-975FD69F-B66A-4536-905D-F17274066662
P50
description
researcher
@en
wetenschapper
@nl
name
Lijoy Varghese
@en
Lijoy Varghese
@nl
type
label
Lijoy Varghese
@en
Lijoy Varghese
@nl
prefLabel
Lijoy Varghese
@en
Lijoy Varghese
@nl
P31
P496
0000-0002-6036-424X